Please login to the form below
rheumatology
This page shows the latest rheumatology news and features for those working in and with pharma, biotech and healthcare.
Novartis’ Cosentyx misses the mark in Humira head-to-head
Novartis continues to reimagine care for patients and advance science in rheumatology.
Latest news
-
GSK pushes rheumatoid arthritis antibody into phase 3
It has taken the decision to push otilimab into phase 3 on the strength of the mid-stage BAROQUE trial, which was reported at the American College of Rheumatology (ACR) congress
-
FDA clears Dupixent as first-ever drug for chronic rhinosinusitis with nasal polyps
Nasal polyps can lead to loss of smell and often patients require surgery to remove the polyps,” said the agency’s head of pulmonary, allergy and rheumatology products Sally Seymour.
-
AbbVie’s upadacitinib tops Humira again in arthritis trial
The lead investigator in the SELECT-EARLY trial, Prof Ronald van Vollenhoven of the Amsterdam Rheumatology and Immunology Centre in the Netherlands, said that while remission is the primary treatment goal
-
Novartis forges AI alliance with Oxford University
It says the Oxford University alliance will be “transformative for how Novartis adopts data science at scale from multiple data sources, beginning with flagship programmes in multiple sclerosis, dermatology and rheumatology.”
-
US ‘unicorn’ Samumed on track with lead arthritis drug
The San Diego company presented data at this week’s American College of Rheumatology (ACR) meeting showing that a single injection of SM04690 into the joints of people with OA of
More from news
Approximately 1 fully matching, plus 73 partially matching documents found.
Latest Intelligence
-
A new era for patient services?
We have already spoken with companies working in rheumatology, oncology and dermatology that are investigating options for enabling these shifts, and industry can be more proactive in finding viable solutions for
-
Staying ahead in the era of precision medicine
It’s revolutionary and it’s evolutionary.”. While it is most advanced in oncology, precision medicine has wider, exciting applications beyond oncology and late-stage disease, such as rheumatology, and rare
-
NHS regional footprints
For example, the CCG has contracted services for musculoskeletal disorders (MSK), from the Nottinghamshire Integrated Care Partnership (ICP), which is now delivering services around rheumatology, arthritis, physiotherapy, imaging, primary care
-
Case study: From Clinical Trials to Real-World Evidence
on Product X’s real-world experience and heritage within dermatology and rheumatology, since these diseases share a common inflammatory mediator targeted by Product X.
-
Case study: Immunology education
There are immunological links between immune-mediated inflammatory diseases (IMIDs) in dermatology, gastroenterology and rheumatology, with patients often presenting with multiple conditions. ... Setting up a virtual biologics clinic (Manchester Royal
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
New hires at EMA, Gilead and BeiGene
Raitt professor of medicine and clinical chief in the division of immunology and rheumatology.
-
Amgen appoints senior VP and head of the European region
Merck Serono, where she was senior VP of strategy and global marketing for neurology, rheumatology and immunology.
-
Bone Therapeutics looks to Pfizer for clinical head
Heynen is a specialist in rheumatology and immunology, with over 35 years of experience in medical and regulatory affairs at local, regional and international levels.
-
Aurora expands its team with three new hires
Mosley (pictured above right) joins the London agency as senior account director and arrives from Tonic Life Communications, where she worked across a number of therapeutic areas including rheumatology, respiratory and
-
Genentech’s Sunil Agarwal joins rare disease firm
He spent just over 10 years at Genentech where his positions included senior VP for immunology and infectious diseases and VP for rheumatology.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
RWE Blog 3: Is real-world evidence the holy grail
Examples include reviews specific to a therapeutic area, such asor rheumatology, which describe RWE findings and contrast them with RCT predictions.
-
Lucid Group supercharges its client services team with four spellbinding new hires
Kristen has worked on a wide variety of educational initiatives in various therapeutic areas, including dermatology, rheumatology, and the rare disease space. “I am so excited to be joining such a
-
Lucid Group welcomes new magical talent and boosts their medical writing teams with hires in the US and UK
Hazel Urwin joins Lucid Partners as a Scientific Director. Hazel has eight years’ experience in medical communications with particular expertise in the fields of neurology, immunology and rheumatology.
-
Bringing the NHS into the 21st century
We have consultants specialising in cardiology, endocrine, ENT, gynaecology, haematology, neurology, respiratory, orthopaedics, rheumatology, and urology.
-
Healthcircle
Rx &Medical Devices. Oncology. Haematology. Rheumatology. Anti-infectives. Anti-virals. Cardiovascular. Respiratory. Endocrinology.
More from PMHub
Approximately 2 fully matching, plus 18 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine
- Gut instincts lead Takeda to GI pipeline success
- How will the events and exhibitions industry change post-Coronavirus?
- China’s CanSino Biologics reveals phase 2 coronavirus vaccine results
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- Roche’s Tecentriq combo scores FDA approval for melanoma
- Socially distanced strategising
- Artificial Intelligence in Digital Therapeutics
- Virtual Reality in Medicine and Clinical Research
- J&J inks $1bn deal with US for coronavirus vaccine
- Novartis builds its case for novel MS treatment ofatumumab
- Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer
PMHub
OPEN Health
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...
Latest intelligence
- Virtual Engagement At Porterhouse: Reflections on the past few months
- A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
- July 2020: diversity and inclusion in clinical trials round-up
- COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Quick links
Infographics
